Cavernous carotid aneurysms: a new treatment paradigm in the era of flow diversion

Daniel M.S. Raper, Dale Ding, Eric C. Peterson, Richard W. Crowley, Kenneth C. Liu, Nohra Chalouhi, David M. Hasan, Aaron S. Dumont, Pascal Jabbour, Robert M. Starke

Research output: Contribution to journalReview article

8 Citations (Scopus)

Abstract

Introduction: Cavernous carotid aneurysms can cause significant symptomatology through mass effect and may rupture, resulting in carotid-cavernous fistula or epistaxis. Traditional treatment options included endovascular or surgical parent vessel occlusion, or embolization; in the last decade, the development of flow-diverting stents has changed the management paradigm for these lesions. Areas covered: In this review, we summarize the natural history, clinical presentation, and evolution of treatment options for cavernous carotid aneurysms and discuss developments likely to influence treatment strategies in the future. We performed a Medline search for relevant review articles and original reports and additional searches based on review of referenced articles, abstracts, and conference presentations. Expert commentary: Long-term data are still required to fully assess the efficacy of endoluminal reconstruction using flow diversion, but this approach appears to offer an attractive therapy for many cavernous carotid aneurysms requiring intervention.

Original languageEnglish (US)
Pages (from-to)155-163
Number of pages9
JournalExpert Review of Neurotherapeutics
Volume17
Issue number2
DOIs
StatePublished - Feb 1 2017

Fingerprint

Aneurysm
Epistaxis
Natural History
Fistula
Stents
Rupture
Therapeutics

All Science Journal Classification (ASJC) codes

  • Neuroscience(all)
  • Clinical Neurology
  • Pharmacology (medical)

Cite this

Raper, D. M. S., Ding, D., Peterson, E. C., Crowley, R. W., Liu, K. C., Chalouhi, N., ... Starke, R. M. (2017). Cavernous carotid aneurysms: a new treatment paradigm in the era of flow diversion. Expert Review of Neurotherapeutics, 17(2), 155-163. https://doi.org/10.1080/14737175.2016.1212661
Raper, Daniel M.S. ; Ding, Dale ; Peterson, Eric C. ; Crowley, Richard W. ; Liu, Kenneth C. ; Chalouhi, Nohra ; Hasan, David M. ; Dumont, Aaron S. ; Jabbour, Pascal ; Starke, Robert M. / Cavernous carotid aneurysms : a new treatment paradigm in the era of flow diversion. In: Expert Review of Neurotherapeutics. 2017 ; Vol. 17, No. 2. pp. 155-163.
@article{8edf15ddf49b442695eec7f0b7b63f6c,
title = "Cavernous carotid aneurysms: a new treatment paradigm in the era of flow diversion",
abstract = "Introduction: Cavernous carotid aneurysms can cause significant symptomatology through mass effect and may rupture, resulting in carotid-cavernous fistula or epistaxis. Traditional treatment options included endovascular or surgical parent vessel occlusion, or embolization; in the last decade, the development of flow-diverting stents has changed the management paradigm for these lesions. Areas covered: In this review, we summarize the natural history, clinical presentation, and evolution of treatment options for cavernous carotid aneurysms and discuss developments likely to influence treatment strategies in the future. We performed a Medline search for relevant review articles and original reports and additional searches based on review of referenced articles, abstracts, and conference presentations. Expert commentary: Long-term data are still required to fully assess the efficacy of endoluminal reconstruction using flow diversion, but this approach appears to offer an attractive therapy for many cavernous carotid aneurysms requiring intervention.",
author = "Raper, {Daniel M.S.} and Dale Ding and Peterson, {Eric C.} and Crowley, {Richard W.} and Liu, {Kenneth C.} and Nohra Chalouhi and Hasan, {David M.} and Dumont, {Aaron S.} and Pascal Jabbour and Starke, {Robert M.}",
year = "2017",
month = "2",
day = "1",
doi = "10.1080/14737175.2016.1212661",
language = "English (US)",
volume = "17",
pages = "155--163",
journal = "Expert Review of Neurotherapeutics",
issn = "1473-7175",
publisher = "Expert Reviews Ltd.",
number = "2",

}

Raper, DMS, Ding, D, Peterson, EC, Crowley, RW, Liu, KC, Chalouhi, N, Hasan, DM, Dumont, AS, Jabbour, P & Starke, RM 2017, 'Cavernous carotid aneurysms: a new treatment paradigm in the era of flow diversion', Expert Review of Neurotherapeutics, vol. 17, no. 2, pp. 155-163. https://doi.org/10.1080/14737175.2016.1212661

Cavernous carotid aneurysms : a new treatment paradigm in the era of flow diversion. / Raper, Daniel M.S.; Ding, Dale; Peterson, Eric C.; Crowley, Richard W.; Liu, Kenneth C.; Chalouhi, Nohra; Hasan, David M.; Dumont, Aaron S.; Jabbour, Pascal; Starke, Robert M.

In: Expert Review of Neurotherapeutics, Vol. 17, No. 2, 01.02.2017, p. 155-163.

Research output: Contribution to journalReview article

TY - JOUR

T1 - Cavernous carotid aneurysms

T2 - a new treatment paradigm in the era of flow diversion

AU - Raper, Daniel M.S.

AU - Ding, Dale

AU - Peterson, Eric C.

AU - Crowley, Richard W.

AU - Liu, Kenneth C.

AU - Chalouhi, Nohra

AU - Hasan, David M.

AU - Dumont, Aaron S.

AU - Jabbour, Pascal

AU - Starke, Robert M.

PY - 2017/2/1

Y1 - 2017/2/1

N2 - Introduction: Cavernous carotid aneurysms can cause significant symptomatology through mass effect and may rupture, resulting in carotid-cavernous fistula or epistaxis. Traditional treatment options included endovascular or surgical parent vessel occlusion, or embolization; in the last decade, the development of flow-diverting stents has changed the management paradigm for these lesions. Areas covered: In this review, we summarize the natural history, clinical presentation, and evolution of treatment options for cavernous carotid aneurysms and discuss developments likely to influence treatment strategies in the future. We performed a Medline search for relevant review articles and original reports and additional searches based on review of referenced articles, abstracts, and conference presentations. Expert commentary: Long-term data are still required to fully assess the efficacy of endoluminal reconstruction using flow diversion, but this approach appears to offer an attractive therapy for many cavernous carotid aneurysms requiring intervention.

AB - Introduction: Cavernous carotid aneurysms can cause significant symptomatology through mass effect and may rupture, resulting in carotid-cavernous fistula or epistaxis. Traditional treatment options included endovascular or surgical parent vessel occlusion, or embolization; in the last decade, the development of flow-diverting stents has changed the management paradigm for these lesions. Areas covered: In this review, we summarize the natural history, clinical presentation, and evolution of treatment options for cavernous carotid aneurysms and discuss developments likely to influence treatment strategies in the future. We performed a Medline search for relevant review articles and original reports and additional searches based on review of referenced articles, abstracts, and conference presentations. Expert commentary: Long-term data are still required to fully assess the efficacy of endoluminal reconstruction using flow diversion, but this approach appears to offer an attractive therapy for many cavernous carotid aneurysms requiring intervention.

UR - http://www.scopus.com/inward/record.url?scp=85007496715&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85007496715&partnerID=8YFLogxK

U2 - 10.1080/14737175.2016.1212661

DO - 10.1080/14737175.2016.1212661

M3 - Review article

C2 - 27451048

AN - SCOPUS:85007496715

VL - 17

SP - 155

EP - 163

JO - Expert Review of Neurotherapeutics

JF - Expert Review of Neurotherapeutics

SN - 1473-7175

IS - 2

ER -